IceCure Medical Ltd (ICCM) 追踪市盈率为负值 -1.7, 表示公司目前在过去十二个月 (TTM) 基础上处于亏损状态。 前瞻市盈率 4.4 基于分析师预估，预计将恢复盈利。 追踪盈利收益率为 -60.34%, 前瞻盈利收益率 22.52%. PEG 0.03 (Peter Lynch 低估标准 ≤1.0).
本页证实的标准:
SharesGrow 综合评分： 54/100 其中 3/7 项标准通过。
| Year | P/E (TTM) | PEG 比率 | P/B 比率 | P/S 比率 | 股息收益率 |
|---|---|---|---|---|---|
| 2016 | -17.7 | 0.72 | 27.48 | 92.38 | - |
| 2017 | -23.7 | 0.92 | -265.59 | 98.99 | - |
| 2018 | -36.0 | 1.03 | 37.77 | 118.65 | - |
| 2019 | -31.2 | -1.87 | 56.53 | 89.57 | - |
| 2020 | -39.1 | 1.95 | 40.74 | 45.71 | - |
| 2021 | -8.7 | -0.35 | 3.23 | 21.04 | - |
| 2022 | -3.3 | -0.10 | 2.26 | 18.60 | - |
| 2023 | -3.3 | 0.10 | 4.01 | 15.12 | - |
| 2024 | -3.7 | 0.58 | 8.11 | 17.01 | - |
| 2025 | -2.6 | 0.13 | 4.29 | 11.48 | - |
| Year | EPS（稀释） | 营收 | 净利润 | 净利润率 |
|---|---|---|---|---|
| 2016 | $-0.62 | $625.49K | $-3.27M | -522.8% |
| 2017 | $-0.46 | $689.38K | $-2.88M | -417.2% |
| 2018 | $-0.30 | $1.07M | $-3.53M | -329.7% |
| 2019 | $-0.35 | $1.66M | $-4.76M | -287.2% |
| 2020 | $-0.28 | $4.08M | $-4.78M | -117% |
| 2021 | $-0.35 | $4.14M | $-10.07M | -243.3% |
| 2022 | $-0.47 | $3.09M | $-17.22M | -558.1% |
| 2023 | $-0.32 | $3.23M | $-14.65M | -453.8% |
| 2024 | $-0.31 | $3.29M | $-15.32M | -465.5% |
| 2025 | $-0.24 | $3.38M | $-15.06M | -445.6% |
| Year | EPS（平均） | EPS 范围 | 营收（平均） | 营收范围 | 分析师人数 |
|---|---|---|---|---|---|
| 2026 | $-0.19 | $-0.23 – $-0.14 | $7.93M | $6.56M – $9.31M | 1 |
| 2027 | $-0.15 | $-0.18 – $-0.12 | $13.94M | $11.52M – $16.35M | 1 |
| 2028 | $-0.04 | $-0.05 – $-0.03 | $33.7M | $27.86M – $39.54M | 1 |
| 2029 | $0.08 | $0.06 – $0.10 | $54.96M | $45.44M – $64.48M | 1 |
| 2030 | $0.21 | $0.16 – $0.26 | $78.62M | $65M – $92.24M | 1 |
